高级搜索

GANT61诱导食管鳞癌细胞凋亡的作用及其机制

王雷, 杜媛鲲, 王林, 米源, 廖海江

王雷, 杜媛鲲, 王林, 米源, 廖海江. GANT61诱导食管鳞癌细胞凋亡的作用及其机制[J]. 肿瘤防治研究, 2016, 43(8): 659-662. DOI: 10.3971/j.issn.1000-8578.2016.08.002
引用本文: 王雷, 杜媛鲲, 王林, 米源, 廖海江. GANT61诱导食管鳞癌细胞凋亡的作用及其机制[J]. 肿瘤防治研究, 2016, 43(8): 659-662. DOI: 10.3971/j.issn.1000-8578.2016.08.002
WANG Lei1, DU Yuankun, WANG Lin, MI Yuan, LIAO Haijiang. Effect of GANT61 on Apoptosis of Esophageal Squamous Carcinoma Cells and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2016, 43(8): 659-662. DOI: 10.3971/j.issn.1000-8578.2016.08.002
Citation: WANG Lei1, DU Yuankun, WANG Lin, MI Yuan, LIAO Haijiang. Effect of GANT61 on Apoptosis of Esophageal Squamous Carcinoma Cells and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2016, 43(8): 659-662. DOI: 10.3971/j.issn.1000-8578.2016.08.002

GANT61诱导食管鳞癌细胞凋亡的作用及其机制

基金项目: 

河北省科技厅科技攻关计划 132077127D

详细信息
    作者简介:

    王雷(1976-), 男, 博士, 副教授, 主要从事胸部肿瘤的靶向治疗研究

  • 中图分类号: R735.1

Effect of GANT61 on Apoptosis of Esophageal Squamous Carcinoma Cells and Its Mechanism

  • 摘要:
    目的 

    研究Gli抑制剂GANT61诱导人食管鳞癌细胞OE21和KYSE-30凋亡的机制。

    方法 

    应用不同浓度(0、10、15 μmol/L)的GANT61处理OE21和KYSE-30细胞24 h后, Western blot观察GANT61作用于OE21和KYSE-30细胞后对Gli1、Gli2、Fas和Bcl-2蛋白表达的影响。流式细胞术观察细胞凋亡及Fas、Bcl-2蛋白的表达。

    结果 

    Western blot显示GANT61可以剂量依赖性显著下调OE21和KYSE-30细胞Gli1、Gli2和Bcl-2蛋白表达, 增加Fas蛋白表达。流式细胞术检测显示不同浓度GANT61作用24 h后, OE21和KYSE-30细胞表现出不同程度的细胞凋亡并且呈药物剂量依赖性, 与空白对照组相比差异均有统计学意义(P=0.000);与空白对照组相比, OE21和KYSE-30细胞中Bcl-2蛋白表达水平显著降低且呈药物剂量依赖性, 差异均有统计学意义(P=0.000); Fas蛋白表达水平显著增加且呈药物剂量依赖性, 差异均有统计学意义(P=0.000)。

    结论 

    GANT61明显诱导细胞凋亡, 其作用机制可能与其通过特异性抑制OE21和KYSE-30细胞中Gli1、Gli2表达从而调节Fas和Bcl-2蛋白表达有关。

     

    Abstract:
    Objective 

    To investigate the effect of GANT61 on the apoptosis of esophageal squamous carcinoma cells OE21 and KYSE-30, and to explore its possible mechanism.

    Methods 

    After OE21 and KYSE-30 cell lines were treated with different concentrations(0, 10, 15μmol/L)of GANT61 for 24h, the protein expression of Gli1, Gli2, Fas and bcl-2 were detected by Western blot. Cell apoptosis, Fas and bcl-2 expression levels of OE21 and KYSE-30 cell lines were measured by flow cytometry.

    Results 

    Western blot assay showed that GANT61 decreased Gli1, Gli2, Bcl-2 protein expression and increased Fas protein expression in a dose-dependent manner. Compared with DMSO group, the apoptotic rates of OE21 and KYSE-30 cell lines were significantly increased in a dose-dependent manner(P=0.000); the Bcl-2 protein expression levels were significantly decreased in a dose-dependent manner(P=0.000); the Fas protein expression levels were significantly increased in a dose-dependent manner(P=0.000).

    Conclusion 

    GANT61 could enhance the apoptotic rates of OE21 and KYSE-30 cells, and this effect may be associated with GANT61 decreasing Gli1 and Gli2 expression to regulate Fas and Bcl-2 protein expression levels in esophageal squamous carcinoma cells.

     

  • 图  1   流式细胞术检测GANT61对OE21、KYSE-30细胞的诱导凋亡作用

    Figure  1   Apoptosis of OE21 and KYSE-30 cells induced by GANT61 detected by FCM

    图  2   Western blot方法检测OE21细胞中蛋白表达水平

    Figure  2   Protein expression of OE21 cells detected by Western blot

    图  3   Western blot方法检测KYSE-30细胞中蛋白表达水平

    Figure  3   Protein expression of KYSE-30 cells detected by Western blot

    表  1   流式细胞术检测不同浓度GANT61作用OE21、KYSE-30细胞24 h细胞中Bcl-2和Fas蛋白表达水平 (x±s, n=5)

    Table  1   Bcl-2 and Fas protein expression levels in OE21, KYSE-30 cells after treated with different concentrations of GANT61 for 24h detected by flow cytometry (x±s, n=5)

    下载: 导出CSV
  • [1]

    Athar M, Li C, Kim AL, et al. Sonic hedgehog signaling in Basal cell nevus syndrome[J]. Cancer Res, 2014, 74(18): 4967-75. doi: 10.1158/0008-5472.CAN-14-1666

    [1] Athar M, Li C, Kim AL, et al. Sonic hedgehog signaling in Basal cell nevus syndrome[J]. Cancer Res, 2014, 74(18): 4967-75.
    [2] Campbell V, Copland M. Hedgehog signaling in cancer stem cells: a focus on hematological cancers[J]. Stem Cells Cloning, 2015, 8: 27 -38.
    [2]

    Campbell V, Copland M. Hedgehog signaling in cancer stem cells: a focus on hematological cancers[J]. Stem Cells Cloning, 2015, 8: 27-38. http://cn.bing.com/academic/profile?id=1980798201&encoded=0&v=paper_preview&mkt=zh-cn

    [3] Chandra V, Das T, Gulati P, et al. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters[J]. PLoS One, 2015, 10(3): e0116390.
    [3]

    Chandra V, Das T, Gulati P, et al. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters[J]. PLoS One, 2015, 10(3): e0116390. doi: 10.1371/journal.pone.0116390

    [4] Felley-Bosco E, Opitz I, Meerang M. Hedgehog Signaling in Malignant Pleural Mesothelioma[J]. Genes (Basel), 2015, 6(3): 50 0-11.
    [4]

    Felley-Bosco E, Opitz I, Meerang M. Hedgehog Signaling in Malignant Pleural Mesothelioma[J]. Genes (Basel), 2015, 6(3): 500-11. http://cn.bing.com/academic/profile?id=1558724718&encoded=0&v=paper_preview&mkt=zh-cn

    [5] Islam SS, Mokhtari RB, Noman AS, et al. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer[J]. Mol Carcinog, 2016, 55(5): 537-51.
    [5]

    Islam SS, Mokhtari RB, Noman AS, et al. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer[J]. Mol Carcinog, 2016, 55(5): 537-51. doi: 10.1002/mc.v55.5

    [6] Behnsawy HM, Shigemura K, Meligy FY, et al. Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression[J]. Korean J Urol, 2013, 54(8): 547-54.
    [6]

    Behnsawy HM, Shigemura K, Meligy FY, et al. Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression[J]. Korean J Urol, 2013, 54(8): 547-54. doi: 10.4111/kju.2013.54.8.547

    [7]

    Srivastava RK, Kaylani SZ, Edrees N, et al. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis[J]. Oncotarget, 2014, 5(23): 12151-65. doi: 10.18632/oncotarget

    [7] Srivastava RK, Kaylani SZ, Edrees N, et al. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis[J]. Oncotarget, 2014, 5( 23): 12151-65.
    [8] Wang Y, Han C, Lu L, et al. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells[J]. Hepatology, 2013, 58(3): 995-1010.
    [8]

    Wang Y, Han C, Lu L, et al. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells[J]. Hepatology, 2013, 58(3): 995-1010. doi: 10.1002/hep.v58.3

    [9]

    Wellbrock J, Latuske E, Kohler J, et al. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects[J]. Clin Cancer Res, 2015, 21(10): 2388-98. doi: 10.1158/1078-0432.CCR-14-1059

    [9] Wellbrock J, Latuske E, Kohler J, et al. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects[J]. Clin Cancer Res, 2015, 21(10): 2388-98.
    [10] Regl G, Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2[J]. Cancer Res, 2004, 64(21): 77 24-31.
    [10]

    Regl G, Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2[J]. Cancer Res, 2004, 64(21): 7724-31. doi: 10.1158/0008-5472.CAN-04-1085

    [11] Fu J, Rodova M, Roy SK, et al. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft[J]. Cancer Lett, 2013, 330(1): 22-32.
    [11]

    Fu J, Rodova M, Roy SK, et al. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft[J]. Cancer Lett, 2013, 330(1): 22-32. doi: 10.1016/j.canlet.2012.11.018

图(3)  /  表(1)
计量
  • 文章访问数:  1151
  • HTML全文浏览量:  388
  • PDF下载量:  379
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-12-29
  • 修回日期:  2016-05-16
  • 网络出版日期:  2024-02-04
  • 刊出日期:  2016-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭